Dyrk1A-ASF-CaMKIIδ Signaling: New Mechanistic Insight Involved in Valsartan Inhibition of Cardiac Hypertrophy?

Publisher： Karger

E-ISSN： 1421-9751|133|4|211-212

ISSN： 0008-6312

Source： Cardiology, Vol.133, Iss.4, 2015-12, pp. : 211-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dyrk1A-ASF-CaMKIIδ Signaling Is Involved in Valsartan Inhibition of Cardiac Hypertrophy in Renovascular Hypertensive Rats

By  

Cardiology, Vol. 133, Iss. 3, 2016-0 ,pp. : 198-204

Karger

Access to resources Recommend Favorite

Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress

By  

THE JOURNAL OF PATHOLOGY, Vol. 235, Iss. 4, 2015-03 ,pp. : 606-618

John Wiley & Sons Inc

Access to resources Recommend Favorite

Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo

By                

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 499-506

Spandidos Publications

Access to resources Recommend Favorite

Erratum‐ovarian cancer cells, not normal cells, are damaged by mirk/dyrk1b kinase inhibition

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : E13-E13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Downregulation of miR‐21 is Involved in Direct Actions of Ursolic Acid on the Heart: Implications for Cardiac Fibrosis and Hypertrophy

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 4, 2015-08 ,pp. : 161-167

John Wiley & Sons Inc

Access to resources Recommend Favorite